Results for tag: "Neuroendocrine Tumor Drug"

The Neuroendocrine Tumor Drug market is a subset of the Oncology Drugs market, focusing on drugs used to treat neuroendocrine tumors. Neuroendocrine tumors are a type of cancer that originate in the neuroendocrine cells, which are found in various parts of the body. These tumors can be benign or malignant, and can cause a variety of symptoms, including abdominal pain, diarrhea, and weight loss. Treatment for neuroendocrine tumors typically involves a combination of surgery, chemotherapy, and radiation therapy. Drugs used to treat neuroendocrine tumors include somatostatin analogs, such as octreotide and lanreotide, and targeted therapies, such as everolimus and sunitinib. These drugs are used to reduce tumor size, slow tumor growth, and reduce symptoms. Some companies in the Neuroendocrine Tumor Drug market include Novartis, Pfizer, and Merck. Show Less Read more